This gene symbol represents a specific cDNA clone identified during the project and is not a conventional gene symbol that would be found in genetic databases like NCBI's Gene or Ensembl.As a cDNA, or complementary DNA, the 2310057J18 sequence is reverse-transcribed from an mRNA template, which implies that it corresponds to an expressed sequence-a snapshot of gene expression in the tissues sampled during the project. The role of the protein encoded by this cDNA, if it does indeed encode a protein, is not well-defined in scientific literature due to its designation as a cDNA clone name rather than a gene with a well-characterized function.
The typical process of characterization for such a cDNA would involve determining the sequence's genomic location to identify potential regulatory elements, assessing the tissue-specific expression patterns, and conducting studies to ascertain the function of the putative protein product. This could involve examining the protein structure, determining its cellular localization, identifying interaction partners, and investigating its role in physiological and pathological processes.Researchers would typically use such cDNA clones to delve deeper into the gene's role, studying its expression pattern across different developmental stages or physiological conditions, creating knockout models to study the phenotypic consequences of gene disruption, and possibly exploring its implication in diseases if it has conserved homologs in humans or other species.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, potentially reducing the transcription of mRNA and thus the expression of proteins. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates DNA, inhibiting RNA polymerase and reducing mRNA synthesis for protein production. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide represses transcriptional activity of various genes, likely diminishing the protein levels. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA, inhibiting transcription and consequent protein expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB selectively inhibits RNA polymerase II, potentially decreasing transcription and protein expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin disrupts RNA synthesis, which may result in reduced protein expression. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B blocks mRNA export from the nucleus, potentially decreasing protein synthesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A alters chromatin structure and can suppress gene expression, reducing protein levels. | ||||||
Siomycin A | 12656-09-6 | sc-202339 sc-202339-CW sc-202339A sc-202339B | 500 µg 500 µg 2.5 mg 25 mg | $450.00 $500.00 $1350.00 $10404.00 | 4 | |
Siomycin A can inhibit gene transcription, potentially leading to decreased protein expression. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide inhibits translation initiation, potentially leading to reduced protein synthesis. | ||||||